GHK-Cu vs BPC-157 Which repair peptide for which research?
GHK-Cu and BPC-157 are two of the most studied peptides in tissue repair, but their mechanisms of action, target tissues, and research contexts are fundamentally different. This scientific comparison details their respective profiles to guide laboratory selection.
Two approaches to tissue repair
Tissue repair involves numerous signaling pathways: inflammation, angiogenesis, cell proliferation, and matrix remodeling. GHK-Cu and the BPC-157 intervene at distinct levels of this cascade, which makes them complementary rather than interchangeable in research.
Structural and mechanistic comparison
| Characteristic | GHK-Cu | BPC-157 |
|---|---|---|
| Structure | Tripeptide (Gly-His-Lys) + Cu2+ | Pentadecapeptide (15 AA) |
| Molecular mass | 403.9 Da | 1,419.5 Da |
| Origin | Isolated from human plasma (1973) | Human gastric sequence (BPC) |
| Main mechanism | ECM remodeling + Cu2+ delivery | NO system modulation + angiogenesis |
| PubMed publications | ~150 | ~200+ |
| Route of administration under consideration | Topical + local injection | SC + IP + oral |
GHK-Cu: mechanistic profile
Extracellular matrix remodeling
GHK-Cu acts mainly on the extracellular matrix (ECM) and the tissue microenvironment:
- Stimulation of collagen I, III and V synthesis by fibroblasts
- Upregulation of dermal glycosaminoglycans (GAGs) and proteoglycans
- Regulation of metalloproteinases (MMP-2, MMP-9) and their inhibitors (TIMP-1, TIMP-2)
- Stimulation of decorin and fibronectin synthesis
Delivery of bioactive copper
The Cu2+ ion complexed with GHK plays an essential catalytic role:
- Cofactor of lysyl oxidase (cross-linking of collagen and elastin)
- Cofactor of superoxide dismutase (SOD) — antioxidant protection
- Stimulation of angiogenesis via the VEGF factor (copper-dependent pathway)
- Activation of mitochondrial cytochrome c oxidase
GHK-Cu genomics
Analysis of the Connectivity Map revealed that GHK-Cu modulates the expression of 4,000+ genes humans, including 1,584 genes linked to tissue repair. Major clusters include:
- Anti-fibrotic genes (TGF-beta signaling downregulation)
- Antioxidant and detoxification genes
- Collagen synthesis and ECM remodeling genes
BPC-157: mechanistic profile
NO system and angiogenesis
The BPC-157 primarily targets the nitric oxide system and neovascularization:
- Activation of eNOS (endothelial nitric oxide synthase)
- Promotion of local angiogenesis via VEGF and FGF-2
- Formation of collateral vessels in ischemic areas
- Endothelial protection against oxidative stress
Multi-tissue repair
Unlike GHK-Cu, which primarily targets the skin and matrix, BPC-157 shows effects on multiple fabrics :
- Tendons: stimulation of tendon fibroblasts and cell migration
- Muscle: accelerated regeneration of striated muscle fibers
- Intestine: protection of the gastric mucosa, healing of ulcers
- Bone: Stimulation of osteogenesis in fracture models
- Nerves: promoting axonal regeneration after section
Optimal search contexts
| Research context | GHK-Cu | BPC-157 |
|---|---|---|
| Skin healing / wounds | Excellent (topic) | Good (systemic) |
| Tendon repair | Limit | Excellent |
| Gastrointestinal protection | Not studied | Excellent |
| Skin anti-aging / photoaging | Excellent | Not studied |
| Muscle repair | Moderate | Good |
| Neuroprotection | Moderate (Cu/SOD route) | Good (NW track) |
| Anti-fibrosis | Excellent (TGF-beta) | Moderate |
| Local angiogenesis | Moderate | Excellent |
Pharmacological comparison
| Setting | GHK-Cu | BPC-157 |
|---|---|---|
| Stability in solution | Good (stable Cu complex) | Excellent (resistant to gastric juices) |
| Topical route | Effective (penetrates the epidermis) | Not studied significantly |
| Systemic route (SC/IP) | Little studied | Well documented |
| Oral route | Undocumented | Active (gastric stability) |
| Toxicity | Very low (natural plasma component) | Very low (no toxicity observed in vivo) |
GHK-Cu and BPC-157 can be studied in combination in wound healing protocols, their mechanisms being non-competitive: GHK-Cu targets matrix remodeling while BPC-157 targets vascularization and NO signaling.
How to choose in the laboratory
- Skin research / anti-aging / fibrosis → GHK-Cu (topical application, ECM remodeling)
- Search tendon / muscle / intestine → BPC-157 (multi-tissue systemic action)
- Combined wound healing models → both (complementary mechanisms)
- Search for pure angiogenesis → BPC-157 (direct NW/VEGF route)
- Anti-fibrotic research → GHK-Cu (documented TGF-beta modulation)
GHK-Cu and BPC-157 certified HPLC 99%+
MyPeptide offers research-grade GHK-Cu and BPC-157 with Janoshik certificates of analysis. Shipping from the European Union in 48-72 hours.
Scientific sources
- The human tripeptide GHK-Cu and oxidative stress — Pickart L et al. (2012)
- GHK peptide as a natural modulator of multiple cellular pathways — Pickart L et al. (2015)
- BPC-157 in regeneration and analgesia — Yuan C et al. (2026)
- BPC-157 for musculoskeletal healing — narrative review — McGuire FP et al. (2025)